The Application Value of Intercostal Suturing in Preventing Postoperative Thoracoscopic Lung Resection Chest Wall Pulmonary Hernia
Launched by MINGJIAN GE · Apr 5, 2025
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing lung resection via multiport thoracoscopic surgery:The intercostal muscles at the main incision site need to be dissected using an electrocautery knife.Intercostal incisions should be used with a retractor and an incision protector to prevent damage to intercostal nerves and blood vessels,as well as rib fractures.
- • Age greater than or equal to 18 years No history of thoracic surgery
- Exclusion Criteria:
- • During the operation,if a patient's multiport thoracoscopic surgery needs to be converted to a thoracoscopic-assisted mini-thoracotomy,a rib retractor becomes necessary.
- • During the operation,conversion to thoracotomy or a conventional posterolateral incision may be necessary based on the specific intraoperative circumstances.
- • Uniportal thoracoscopic surgery History of ipsilateral thoracic surgery
About Mingjian Ge
Mingjian Ge is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on precision medicine, the organization conducts rigorous clinical trials across various therapeutic areas, leveraging cutting-edge methodologies and technologies. Mingjian Ge collaborates with a network of esteemed research institutions and healthcare professionals to ensure the highest standards of safety, efficacy, and regulatory compliance. By prioritizing patient-centered approaches and fostering transparency, Mingjian Ge aims to contribute significantly to the development of new treatments that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chongqing, Chongqing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported